newsfilter
← Latest News
FDA Approved Drugs·

Approval of Xphozah, Nda #213931 (Labeling)

Approval Date: 06/16/2025; Drug Name: Xphozah, Nda #213931; Active Ingredients: TENAPANOR HYDROCHLORIDE; Company: Ardelyx Inc; Submission Status: Approval; Submission Classification: Labeling; Application Number: 213931

Company
ARDELYX INC
Keywords
ARDELYX INC